Pharvaris (PHVS) Receivables (2019 - 2026)
Pharvaris (PHVS) recorded Receivables of $1.24 trillion in Q2 2026, compared with $2.94 million a year earlier and up 9.6% from the prior quarter.
Powered by 
Analysis
Pharvaris (PHVS) Receivables (2019 - 2026) Analysis & Trends
At the end of FY2025, Pharvaris reported Receivables of $629.01 billion, up 26.9% from FY2024.
- Annual Receivables has increased for three straight years, though with a five-year compound annual growth rate of -0.7% (FY2020 to FY2025).
- Across earlier years, Receivables came in at $495.53 billion in FY2024 (+8.2%), $458.09 billion in FY2023 (+13.6%), $403.1 billion in FY2022 (-51.3%) and $828.47 billion in FY2021 (+27.4%).
- The Q2 2026 figure is the highest quarterly Receivables in data going back to Q4 2019.
- On a year-over-year basis, Receivables rose in two of the last five quarters, with an average decline of 36.4%.
- Peak year-over-year performance for Receivables in the last five years was growth of 110.8% in Q3 2024, against a decline of 100.0% in Q1 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Pharvaris | 2.08 Bn | -289,124.32 Bn | 85,072.10 | 1,244.59 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,244.59 Bn |
| Mar 31, 2026 | 1,135.18 Bn |
| Dec 31, 2025 | 5.30 Mn |
| Jun 30, 2025 | 2.94 Mn |
| Mar 31, 2025 | 613,376.96 |
| Dec 31, 2024 | 489.24 Bn |
| Sep 30, 2024 | 708.78 Bn |
| Jun 30, 2024 | 554.92 Bn |
| Mar 31, 2024 | 394.43 Bn |
| Dec 31, 2023 | 455.65 Bn |
| Sep 30, 2023 | 336.21 Bn |
| Jun 30, 2023 | 364.03 Bn |
| Mar 31, 2023 | 422.98 Bn |
| Dec 31, 2022 | 390.21 Bn |
| Sep 30, 2022 | 407,499.11 |
| Jun 30, 2022 | 354,185.99 |
| Mar 31, 2022 | 750,859.65 |
| Dec 31, 2021 | 800.87 Bn |
| Sep 30, 2021 | 745,742.39 |
| Jun 30, 2021 | 858,362.53 |
API Access
Pharvaris Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=PHVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "PHVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=PHVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();